Back
Reneo Pharmaceuticals 10K Form
Sell
23
RPHM
Reneo Pharmaceuticals
Last Price:
1.50
Seasonality Move:
-26.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RPHM News And Ratings
See the #1 stock for the next 7 days that we like better than RPHM
RPHM Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-6.81M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.30 |
| Price / Book: | 0.65 |
Profitability
| EPS (TTM): | -1.69000 |
|---|---|
| Net Income (TTM): | $-56.54M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Reneo Pharmaceuticals Earnings Forecast
Key Reneo Pharmaceuticals Financial Ratios
- Per Share Earnings over the last 5 years have been positive in 2 years.
Reneo Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RPHM |
| Website: | reneopharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RPHM Technical Analysis vs Fundamental Analysis
Sell
23
Reneo Pharmaceuticals (RPHM)
is a Sell
Is Reneo Pharmaceuticals a Buy or a Sell?
-
Reneo Pharmaceuticals stock is rated a Sell
The current Reneo Pharmaceuticals [RPHM] share price is $1.50. The Score for RPHM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.